Retina Gallery ~ Full Sized Retina Images

Puncate Inner Choroidopathy (PIC) and CNVM - 27 year old female 27 year old female with 4 months vision loss in the right eye. She had no subretinal fluid on presentation. Her vision improved from 20/200 to 20/50 with Lucentis. She has multifocal small scars consistent with a prior episode of PIC
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36227 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 35527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 35927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 38327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 34727 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40627 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 42727 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 34827 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40227 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 35427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 34527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 35427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 34427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 30927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36227 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 33027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36627 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36627 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36827 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 34527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 35927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 33527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36227 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 34627 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 38227 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 38427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 35727 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
38 faili 1 lehel

27 year old female with 4 months vision loss in the right eye. She had no subretinal fluid on presentation. Her vision improved from 20/200 to 20/50 with Lucentis. She has multifocal small scars consistent with a prior episode of PIC